This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Should You Buy Altria (MO) Ahead of Q1 Earnings Release?
by Zacks Equity Research
Despite facing several challenges, we maintain our belief in Altria's (MO) strong fundamentals and its potential for growth.
Altria (MO) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.09, marking a +1.91% move from the previous day.
Helen of Troy (HELE) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter performance is likely to reflect the adverse impact of pressured consumer spending. Persistent inflationary headwinds are a concern.
Want Better Returns? Don?t Ignore These 2 Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Altria (MO) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark (KMB) Q1 Earnings Coming Up: Is a Beat Likely?
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter results are likely to reflect manufacturing cost inflation and volume concerns in some markets, while brand strength and the FORCE program are likely to have aided.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria (MO) Stock Moves -0.24%: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Altria (MO) stood at $40.95, denoting a -0.24% change from the preceding trading day.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Top Research Reports for ServiceNow, Progressive & Analog Devices
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including ServiceNow, Inc. (NOW), The Progressive Corporation (PGR) and Analog Devices, Inc. (ADI).
Altria's (MO) Smoke-Free Strength Helps Navigate Challenges
by Zacks Equity Research
Altria (MO) benefits from its focus on smoke-free product expansion and pricing power amid low cigarette volumes.
Altria (MO) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
Altria (MO) closed at $41.96 in the latest trading session, marking a +0.74% move from the prior day.
Beer Business to Aid Constellation Brands (STZ) in Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q4 results are expected to reflect gains from strong beer business trends as well as growth of Power Brands.
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Altria (MO) Stock Moves -0.67%: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.93, marking a -0.67% move from the previous day.
Altria (MO) Rises Higher Than Market: Key Facts
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $43.66, representing a +1.25% change from its previous close.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Consumer Staples Names
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Altria (MO) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Altria (MO) settling at $44.95, representing a +0.36% change from its previous close.
Altria (MO) Gains on Pricing Power & Smoke-Free Strength
by Zacks Equity Research
Altria (MO) benefits from its pricing power and focus on smoke-free products amid soft cigarette volumes.
Why Altria (MO) Dipped More Than Broader Market Today
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $43.87, moving -0.93% from the previous trading session.
Altria (MO) Ups Earnings View, Expands Share Buyback Plans
by Zacks Equity Research
Altria (MO) divests 35 million shares of Anheuser-Busch InBev. Management expands share repurchase plans while raising the bottom-line view for 2024.
Altria (MO) Plans to Sell Partial Stake in Anheuser-Busch InBev
by Zacks Equity Research
Altria (MO) reveals intentions to divest a portion of its stake in Anheuser-Busch InBev SA/NA via a global secondary offering.
Altria (MO) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $43.35, moving +0.7% from the previous trading session.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.